Turning Point Therapeutics, Inc. - stock earnings
Stock symbol TPTX is outdated, potentially delisted? Maybe it is available on other exchange?
TPTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q1 | -74.4 million USD | 429000 USD |
| 2021Q4 | -78.4 million USD | ? USD |
| 2021Q3 | -66.3 million USD | 460000 USD |
| 2021Q2 | -56.3 million USD | 5.2 million USD |
| 2021Q1 | -35.5 million USD | 25.2 million USD |
| 2020Q4 | -47.4 million USD | ? USD |
| 2020Q3 | -17.7 million USD | 25.0 million USD |
TPTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -236.6 million USD | 30.8 million USD |
| 2020 | -157.3 million USD | 25.0 million USD |
| 2019 | -72.1 million USD | ? USD |
| 2018 | -24.8 million USD | ? USD |
| 2017 | -16.6 million USD | ? USD |
TPTX
Price: $75.49
52 week price:
Earnings Per Share: -4.75 USD
P/E Ratio: -31.45
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 2.8 million
Market Capitalization: 3.8 billion